XT
POM

XTX Topco’s Pomdoctor Ltd POM Stock Holding History

XTX Topco’s Portfolio POM Stock Details POM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,413
Closed -$48.1K – 4895
2026
Q1 		$48.1K Sell
10,413
-10,107
-49% -$51.8K ﹤0.01% 3331
2025
Q4 		$109K Buy
+20,520
New +$1.34M ﹤0.01% 2613

Other funds holding POM

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

XTX Topco's POM Position: Q2 2026 in Review

XTX Topco sold out of Pomdoctor Ltd (POM) in Q2 2026, closing a stake of 10,413 shares — an estimated $48.1K sold.

XTX Topco first reported a position in POM in Q4 2025 and held it in 2 quarters. The position peaked at $109K in Q4 2025. 6 funds tracked by Wall St. Rank hold POM as of Q2 2026.

  • XTX Topco reported no remaining Pomdoctor Ltd position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 10,413 Pomdoctor Ltd shares in Q2 2026, an estimated $48.1K.
  • XTX Topco first reported a position in Pomdoctor Ltd in Q4 2025 and held it in 2 quarters.
  • XTX Topco's Pomdoctor Ltd position peaked at $109K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Pomdoctor Ltd as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.